175 related articles for article (PubMed ID: 22401818)
1. Deletion of the Scl +19 enhancer increases the blood stem cell compartment without affecting the formation of mature blood lineages.
Spensberger D; Kotsopoulou E; Ferreira R; Broccardo C; Scott LM; Fourouclas N; Ottersbach K; Green AR; Göttgens B
Exp Hematol; 2012 Jul; 40(7):588-598.e1. PubMed ID: 22401818
[TBL] [Abstract][Full Text] [Related]
2. Impaired in vitro erythropoiesis following deletion of the Scl (Tal1) +40 enhancer is largely compensated for in vivo despite a significant reduction in expression.
Ferreira R; Spensberger D; Silber Y; Dimond A; Li J; Green AR; Göttgens B
Mol Cell Biol; 2013 Mar; 33(6):1254-66. PubMed ID: 23319051
[TBL] [Abstract][Full Text] [Related]
3. The scl +18/19 stem cell enhancer is not required for hematopoiesis: identification of a 5' bifunctional hematopoietic-endothelial enhancer bound by Fli-1 and Elf-1.
Göttgens B; Broccardo C; Sanchez MJ; Deveaux S; Murphy G; Göthert JR; Kotsopoulou E; Kinston S; Delaney L; Piltz S; Barton LM; Knezevic K; Erber WN; Begley CG; Frampton J; Green AR
Mol Cell Biol; 2004 Mar; 24(5):1870-83. PubMed ID: 14966269
[TBL] [Abstract][Full Text] [Related]
4. The SCL +40 enhancer targets the midbrain together with primitive and definitive hematopoiesis and is regulated by SCL and GATA proteins.
Ogilvy S; Ferreira R; Piltz SG; Bowen JM; Göttgens B; Green AR
Mol Cell Biol; 2007 Oct; 27(20):7206-19. PubMed ID: 17709394
[TBL] [Abstract][Full Text] [Related]
5. Mef2C is a lineage-restricted target of Scl/Tal1 and regulates megakaryopoiesis and B-cell homeostasis.
Gekas C; Rhodes KE; Gereige LM; Helgadottir H; Ferrari R; Kurdistani SK; Montecino-Rodriguez E; Bassel-Duby R; Olson E; Krivtsov AV; Armstrong S; Orkin SH; Pellegrini M; Mikkola HK
Blood; 2009 Apr; 113(15):3461-71. PubMed ID: 19211936
[TBL] [Abstract][Full Text] [Related]
6. Selective rescue of early haematopoietic progenitors in Scl(-/-) mice by expressing Scl under the control of a stem cell enhancer.
Sánchez MJ; Bockamp EO; Miller J; Gambardella L; Green AR
Development; 2001 Dec; 128(23):4815-27. PubMed ID: 11731461
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of the SCL locus: identification of an enhancer that targets the primitive erythroid lineage in vivo.
Delabesse E; Ogilvy S; Chapman MA; Piltz SG; Gottgens B; Green AR
Mol Cell Biol; 2005 Jun; 25(12):5215-25. PubMed ID: 15923636
[TBL] [Abstract][Full Text] [Related]
8. The SCL 3' enhancer responds to Hedgehog signaling during hemangioblast specification.
Hochman E; Kinston S; Harmelin A; Göttgens B; Izraeli S
Exp Hematol; 2006 Dec; 34(12):1643-50. PubMed ID: 17157160
[TBL] [Abstract][Full Text] [Related]
9. Tie2Cre-mediated gene ablation defines the stem-cell leukemia gene (SCL/tal1)-dependent window during hematopoietic stem-cell development.
Schlaeger TM; Mikkola HK; Gekas C; Helgadottir HB; Orkin SH
Blood; 2005 May; 105(10):3871-4. PubMed ID: 15677556
[TBL] [Abstract][Full Text] [Related]
10. Adult hematopoietic stem and progenitor cells require either Lyl1 or Scl for survival.
Souroullas GP; Salmon JM; Sablitzky F; Curtis DJ; Goodell MA
Cell Stem Cell; 2009 Feb; 4(2):180-6. PubMed ID: 19200805
[TBL] [Abstract][Full Text] [Related]
11. SCL expression at critical points in human hematopoietic lineage commitment.
Zhang Y; Payne KJ; Zhu Y; Price MA; Parrish YK; Zielinska E; Barsky LW; Crooks GM
Stem Cells; 2005; 23(6):852-60. PubMed ID: 15917481
[TBL] [Abstract][Full Text] [Related]
12. Scl regulates the quiescence and the long-term competence of hematopoietic stem cells.
Lacombe J; Herblot S; Rojas-Sutterlin S; Haman A; Barakat S; Iscove NN; Sauvageau G; Hoang T
Blood; 2010 Jan; 115(4):792-803. PubMed ID: 19850742
[TBL] [Abstract][Full Text] [Related]
13. The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis.
Kallianpur AR; Jordan JE; Brandt SJ
Blood; 1994 Mar; 83(5):1200-8. PubMed ID: 8118024
[TBL] [Abstract][Full Text] [Related]
14. Aberrant mast-cell differentiation in mice lacking the stem-cell leukemia gene.
Salmon JM; Slater NJ; Hall MA; McCormack MP; Nutt SL; Jane SM; Curtis DJ
Blood; 2007 Nov; 110(10):3573-81. PubMed ID: 17644741
[TBL] [Abstract][Full Text] [Related]
15. Transgenic analysis of the stem cell leukemia +19 stem cell enhancer in adult and embryonic hematopoietic and endothelial cells.
Silberstein L; Sánchez MJ; Socolovsky M; Liu Y; Hoffman G; Kinston S; Piltz S; Bowen M; Gambardella L; Green AR; Göttgens B
Stem Cells; 2005 Oct; 23(9):1378-88. PubMed ID: 16051983
[TBL] [Abstract][Full Text] [Related]
16. Gata2, Fli1, and Scl form a recursively wired gene-regulatory circuit during early hematopoietic development.
Pimanda JE; Ottersbach K; Knezevic K; Kinston S; Chan WY; Wilson NK; Landry JR; Wood AD; Kolb-Kokocinski A; Green AR; Tannahill D; Lacaud G; Kouskoff V; Göttgens B
Proc Natl Acad Sci U S A; 2007 Nov; 104(45):17692-7. PubMed ID: 17962413
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor SCL/TAL1 mediates the phosphorylation of MEK/ERK pathway in umbilical cord blood CD34⁺ stem cells during hematopoietic differentiation.
Zhou RQ; Wu JH; Gong YP; Guo Y; Xing HY
Blood Cells Mol Dis; 2014; 53(1-2):39-46. PubMed ID: 24405580
[TBL] [Abstract][Full Text] [Related]
18. Tetracycline-controlled transgenic targeting from the SCL locus directs conditional expression to erythrocytes, megakaryocytes, granulocytes, and c-kit-expressing lineage-negative hematopoietic cells.
Bockamp E; Antunes C; Maringer M; Heck R; Presser K; Beilke S; Ohngemach S; Alt R; Cross M; Sprengel R; Hartwig U; Kaina B; Schmitt S; Eshkind L
Blood; 2006 Sep; 108(5):1533-41. PubMed ID: 16675709
[TBL] [Abstract][Full Text] [Related]
19. Enhanced megakaryocyte and erythroid development from normal human CD34(+) cells: consequence of enforced expression of SCL.
Elwood NJ; Zogos H; Pereira DS; Dick JE; Begley CG
Blood; 1998 May; 91(10):3756-65. PubMed ID: 9573012
[TBL] [Abstract][Full Text] [Related]
20. An SCL 3' enhancer targets developing endothelium together with embryonic and adult haematopoietic progenitors.
Sánchez M; Göttgens B; Sinclair AM; Stanley M; Begley CG; Hunter S; Green AR
Development; 1999 Sep; 126(17):3891-904. PubMed ID: 10433917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
